{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:15:13Z","timestamp":1789215313066,"version":"build-2803163510"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VHRM"],"DOI":"10.2147\/vhrm.s13779","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T04:14:34Z","timestamp":1307506474000},"page":"353","source":"Crossref","is-referenced-by-count":36,"title":["Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure"],"prefix":"10.2147","author":[{"given":"Jean","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,6]]},"container-title":["Vascular Health and Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=10253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:08:19Z","timestamp":1477865299000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/aldosterone-and-aldosterone-receptor-antagonists-in-patients-with-chro-peer-reviewed-article-VHRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/vhrm.s13779","relation":{},"ISSN":["1178-2048"],"issn-type":[{"value":"1178-2048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}